Sonoma Pharmaceuticals, Inc. announced that it has entered into a distribution agreement with Daewoong Pharmaceutical Co. Ltd. for the marketing and distribution of PrimocynTM Skin Solution products in South Korea. Pursuant to the distribution agreement, Daewoong Pharmaceutical will have the exclusive right to market, sell and distribute Primocyn Skin Solution products, containing Sonoma's Microcyn technology, in South Korea.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1899 USD | +0.05% |
|
-1.09% | +5.27% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
101,300 KRW | -0.88% | -2.69% | 843M | ||
0.1899 USD | +0.05% | -1.09% | 3.57M | ||
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.27% | 3.57M | |
+55.19% | 815B | |
+45.05% | 654B | |
-6.09% | 354B | |
+21.92% | 337B | |
+18.85% | 247B | |
+3.23% | 229B | |
+13.68% | 219B | |
+10.86% | 171B | |
-2.78% | 159B |
- Stock Market
- Equities
- SNOA Stock
- News Sonoma Pharmaceuticals, Inc.
- Sonoma Pharmaceuticals Announces Partnership with Daewoong Pharmaceutical for Distribution of Primocyn Skin Care in South Korea